Reverse TME: The “Bottom-UP” Approach to Low Rectal Cancer
Colorectal cancer is the third most common type of cancer diagnosed in United States, and with rectal cancer accounting for approximately the 30% of the cases. In 2016, the American Cancer Society estimated almost 40,000 of new rectal cancer cases, the majority undergoing surgery – a surgery that has traditionally been difficult, especially in cases of obesity, males and with narrow pelvis. The oncologic cornerstone of this surgery is the removal of the mesorectum as an intact specimen en-bloc with a margin-free tumour. Systematic adherence to this principle has been proven to prolong survival and reduce locoregional recurrence.
- 16.Bravo R, Fernández-Hevia M, Jiménez-Toscano M, et al. Transanal Hartmann reversal: a new technique. Surg Endosc. 2016;30(6):2628–31.Google Scholar
- 29.Leroy J, Barry BD, Melani A, et al. No-scar transanal total mesorectal excision: the last step to pure NOTES for colorectal surgery. JAMA Surg. 2013;148:226–30; discussion 31.Google Scholar
- 30.Collinson FJ, Jayne DG, Pigazzi A, et al. An international, multicentre, prospective, randomised, controlled, unblinded, parallel-group trial of robotic-assisted versus standard laparoscopic surgery for the curative treatment of rectal cancer. Int J Color Dis. 2012;27(2):233–41.CrossRefGoogle Scholar